Patents by Inventor John L. Stauffer

John L. Stauffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20220151581
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Application
    Filed: January 27, 2022
    Publication date: May 19, 2022
    Applicant: FibroGen, Inc.
    Inventors: Seth PORTER, John L STAUFFER
  • METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20200113533
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 16, 2020
    Applicant: FibroGen, Inc.
    Inventors: Seth PORTER, John L. Stauffer
  • Methods for treating idiopathic pulmonary fibrosis
    Patent number: 10555713
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: February 11, 2020
    Assignee: FIBROGEN, INC
    Inventors: Seth Porter, John L. Stauffer
  • METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20180310906
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Application
    Filed: July 5, 2018
    Publication date: November 1, 2018
    Applicant: FibroGen, Inc.
    Inventors: Seth Porter, John L. Stauffer
  • Methods for treating idiopathic pulmonary fibrosis
    Patent number: 10039515
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: August 7, 2018
    Assignee: FIBROGEN, INC.
    Inventors: Seth Porter, John L Stauffer
  • METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20170027535
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Application
    Filed: September 13, 2016
    Publication date: February 2, 2017
    Applicant: FibroGen, Inc.
    Inventors: SETH PORTER, John L. Stauffer
  • Methods for treating idiopathic pulmonary fibrosis
    Patent number: 9480449
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IFF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 1, 2016
    Assignee: FIBROGEN, INC.
    Inventors: Seth Porter, John L Stauffer
  • METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20150086483
    Abstract: The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IFF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 26, 2015
    Applicant: FibroGen, Inc.
    Inventors: Seth Porter, John L. Stauffer